The Minnesota Department of Health recently unveiled a pivotal report on the 340B drug pricing program, which provides ...

Minnesota has becomes the first state to release a report examining the 340B drug discount program for "safety-net" hospitals ...

Minnesota releases a report on the 340B Drug Pricing Program, highlighting the need for transparency in healthcare economics.

University of Minnesota researchers detail the loopholes and pitfalls of drug companies’ discounted pricing program and what Minnesota entities are doing to enhance transparency. The 340B Drug Pricing ...

As the federal drug discount program known as 340B has seen rapid growth in recent years, Minnesota's Department of Health is looking to shine a light on where that growth is occurring.The first year ...

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...

A first-of-its-kind state report shows safety-net hospitals and health care providers in Minnesota saw $630 million in extra revenue last year — and probably much more — from an obscure program funded ...

Johnson & Johnson took a bold step by filing a lawsuit on Nov. 12 against the Health Resources and Services Administration over the 340B Drug Pricing Program. The move came following a public ...

This summer, J&J unveiled a plan to give hospitals after-the-fact rebates for two medications in the program, called 340B, instead of upfront discounts, but paused implementation following threats ...

according to a report from the Minnesota Department of Health. Specifically, hospitals received $1.5 billion in discounted medicines under the 340B Drug Discount program, but paid $734 million ...